Fig. 2

Kaplan-Meier graph for comparing survival time according to which adjunctive immunosuppressants were used. The median survival time was 1035 days (range 126–2163 days) in the leflunomide (n = 16) group, 865 days (range 39-2191 days) in the mycophenolate mofetil group (MMF) (n = 26), 441 days (range 11-2176 days) in the cyclosporin group (n = 18), 754 days (range 6-1898 days) in cytarabine group (n = 19), and 132 days (range 23 ~ 1227 days) in the combination of MMF and cytarabine group (n = 9). Dogs that were alive at the end of the study or died for reasons other than MUE were censored. Censored points are marked with dots. There was a significant difference in the survival time between each treatment group (p = 0.016)